MicroceLac® Plus Now Available

We are pleased to announce the launch of MicroceLac® Plus, the upgraded version of our co-processed excipient MicroceLac® 100.
This new product combines 35% lactose monohydrate with 65% microcrystalline cellulose, significantly enhancing tablet compressibility.
Designed specifically for direct compression, MicroceLac® Plus enables the production of robust tablets with high hardness and low friability, even with challenging APIs or high-dose formulations.

Samples are available upon request.
Please feel free to contact us if you have any questions.